Page last updated: 2024-08-18

4-vinyl-1-cyclohexene dioxide and Bone Loss, Osteoclastic

4-vinyl-1-cyclohexene dioxide has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kalam, A; Talegaonkar, S; Vohora, D1

Other Studies

1 other study(ies) available for 4-vinyl-1-cyclohexene dioxide and Bone Loss, Osteoclastic

ArticleYear
Effects of raloxifene against letrozole-induced bone loss in chemically-induced model of menopause in mice.
    Molecular and cellular endocrinology, 2017, 01-15, Volume: 440

    Topics: Adaptor Proteins, Signal Transducing; Animals; Biomarkers; Bone Remodeling; Bone Resorption; Cyclohexenes; Female; Femur; Glycoproteins; Intercellular Signaling Peptides and Proteins; Letrozole; Lumbar Vertebrae; Menopause; Mice; Nitriles; Raloxifene Hydrochloride; Triazoles; Vinyl Compounds

2017